Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2008
10/15/2008CN101287723A Amide alkyl pyridiyl quinolines as nk3 receptor modulators
10/15/2008CN101287707A 激酶抑制剂 Kinase inhibitors
10/15/2008CN101287456A Diphenylurea derivatives useful as potassium channel activators
10/15/2008CN101284808A Compounds and methods for the inhibition of the expression of VCAM-1
10/15/2008CN101284105A Thrombolysis lipid-lowering pellet for curing cardio-cerebrovascular disease
10/15/2008CN101284049A Quality control process of double coptis effervescent tablets
10/15/2008CN101284030A Quality control methods of hairy holly root medicinal materials, extract or hairy holly root preparation
10/15/2008CN101284016A Bezoar vitro bred and solid oral preparation containing the bezoar
10/15/2008CN101284008A IL-4R antagonist and microorganism for generating the IL-4R antagonist
10/15/2008CN101283995A Different pharmaceutical uses alpha2delta ligands
10/15/2008CN101283990A R-albuterol hydrochloride sustained-released fast disintegrating oral tablet and preparation method thereof
10/15/2008CN100425592C Indole derivatives
10/15/2008CN100425257C Chinese medicine for treating acute and chronic pharyngitis and application thereof
10/15/2008CN100425246C Anti-dust nasal cleanser
10/14/2008US7435814 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors
10/14/2008US7435744 Brain disorders; central nervous system disorders; viricides
10/14/2008US7435743 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one
10/14/2008US7435742 potent antagonists of M3 muscarinic receptors; chronic obstructive pulmonary disease; bronchitis, bronchial hyperreactivity, asthma, cough and rhinitis; gastrointestinal disorders; incontinenc; [2-(3,4-Dimethoxyphenyl)ethyl]-(5-methylfuran-2-ylmethyl)carbamic acid (3R)-1 -azabicyclo[2.2.2]oct-3-yl ester
10/14/2008US7435737 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/14/2008US7435736 e.g. (2R-trans) [4-(4-azetidin-3-yl-piperazin-1-yl)-2-benzyl-piperidin-1-yl]-(3,5-bis-trifluoromethyl-phenyl)-methanone;tachykinins, substance P inhibitor; antidepressant, anxiolytic, antiinflammatory agent, cognition activator; neurodegenerative diseases; addiction, sleep, eating disorders
10/14/2008US7435731 Substituted pyrazolo[3,4-d]pyrimadines and methods of using the same
10/14/2008US7435724 Degradation-resistant mononucleoside phosphate compounds
10/14/2008US7435554 Immunoglobulin specific to lung cancer cell surface protein for use as tool in detection and treatment of cell proliferative disorders; immunotherapy; immunodiagnostics; antitumor agents
10/14/2008US7435415 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC)
10/14/2008CA2382880C N-cyclopentyl modulators of chemokine receptor activity
10/14/2008CA2354576C Pharmaceutical preparation for inhalation of an opioid
10/14/2008CA2338649C New phenylethylamine derivatives, processes for preparing them and their use as pharmaceutical compositions
10/14/2008CA2330359C Reduction of postoperative complications of cardiopulmonary bypass (cpb) surgery
10/14/2008CA2309328C Cyclic amine derivatives and their use as drugs
10/14/2008CA2288821C Modulation of human mast cell activation
10/09/2008WO2008121859A1 Methods of using tricyclic compounds in treating sodium channel-mediated diseases or conditions
10/09/2008WO2008121066A1 Novel tricyclic spiropiperidines or spiropyrrolidines and their use as modulators of chemokine receptors
10/09/2008WO2008121065A1 Novel pyrrolidine derivatives as antagonists of the chemokine receptor
10/09/2008WO2008120818A1 Indole derivative having cpla2 inhibitory activity, use of the same and method for producing the same
10/09/2008WO2008120712A1 Pharmaceutical composition, food or beverage capable of enhancing sympathetic nerve activity
10/09/2008WO2008120653A1 Indoledione derivative
10/09/2008WO2008119988A1 New combination for use in the treatment of inflammatory disorders
10/09/2008WO2008119917A1 Quinoline derivatives as crth2 receptor ligands
10/09/2008WO2008119694A1 Benzimidazole cannabinoid agonists
10/09/2008WO2008119146A2 Combi-preparation of phosphoethanolamine and omega-3-fatty acid for treating bronchial asthma and copd
10/09/2008WO2008101052A3 Compositions and methods for treating, reducing, ameliorating, or preventing infections of the ear or upper respiratory tract
10/09/2008WO2008092942A3 Pyridinyl-pyrazole derivatives and their use as potassium channel modulators
10/09/2008WO2008079521A3 Tricyclic heteroaryl compounds useful as inhibitors of janus kinase
10/09/2008WO2008064337A3 Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity
10/09/2008WO2007107706A3 Dimers of heterocyclic compounds for the treatment of copd
10/09/2008WO2007100566A3 Use of dha and ara in the preparation of a composition for regulating gene expression
10/09/2008WO2006074117A3 Silver/water, silver gels and silver-based compositions; and methods for making and using the same
10/09/2008US20080249298 use of heparinoid derivatives for the treatment and diagnosis of disorders which can be treated with heparinoids
10/09/2008US20080249165 Glycosides and Salts Thereof
10/09/2008US20080249154 Preventive and/or Therapeutic Agent For Disease In Which Mitochondrial Benzodiazephine Receptor Participates
10/09/2008US20080249147 Emulsion-Stabilized Preparation
10/09/2008US20080249145 Of N-[2-(Diethylamino)ethyl]-N-(2-{[2-(4-hydroxy-2-oxo-2,3-dihydro-1,3-benzothiazol-7-yl)ethyl]amino}ethyl)-3-[2-(1-naphthyl)ethoxy]propanamide; asthma and chronic obstructive pulmonary disease
10/09/2008US20080249144 Preventive or Therapeutic Agent for Chronic Inflammatory Lung Disease
10/09/2008US20080249128 N-{2-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-2-oxo-ethoxy]-ethyl}-N-ethyl-4-methoxy-2,3,6-trimethyl-phenylsulfonamide; condensing the N-carboxyalkyl phenylsulfonamide with the substituted piperidine; bradykinin receptor antagonists; analgesics; antidiabetics; angiogenesis inhibitors; rheumatic diseases
10/09/2008US20080249127 Muscarinic Acetylcholine Receptor Antagonists
10/09/2008US20080249110 Novel Substituted 3-Sulfur Indoles
10/09/2008US20080249108 treatment of sleep disorders or inflammatory diseases of the bladder by administering N-benzyl-2-phenylpiperazine-1-carboxamides, e.g., 2-(S)-(4-Fluoro-2-methyl-phenyl)-piperazine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoromethyl-phenyl)-ethyl]-methyl-amide methansulfonate
10/09/2008US20080249098 peripheral benzodiazepine receptors; 7-fluoro-N,N,5-trimethyl-4-oxo-3-(pyridin-2-yl)-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-carboxamide; for the treatment of various types of peripheral neuropathies, amyotrophic lateral sclerosis
10/09/2008US20080249091 Indoles Useful in the Treatment of Inflammation
10/09/2008US20080249087 Heterocylic antiviral compounds
10/09/2008US20080249067 antiallergen, viricide, herbicide, autoimmune diseases; screening procedure for the identification of enzymes GcpE and LytB inhibitor; 4-hydroxy-3-methyl-2-butenyl 1-pyrophosphate; precursor of higher isoprenoids in 2-methyl-D-erythritol pathway (MEP)
10/09/2008US20080249037 having biological activity similar to PIM (acyl glycerol phosphatidylinositol manno-oligosacccharide) activity; asthma, allergic rhinitis, dermatitis, psoriasis, inflammatory bowel disease including Crohn's disease and ulcerative colitis, rheumatoid arthritis, multiple sclerosis, diabetes, systemic lupus
10/09/2008US20080249019 Chronic obstructive pulmonary disease, asthma; polypeptide comprising a cytotoxin, a selective targeting domain, and a translocation domain
10/09/2008US20080248043 Antibodies to SARS coronavirus
10/09/2008US20080248005 Isolation and Cultivation of Stem/Progenitor Cells From the Amniotic Membrane of Umbilical Cord and Uses of Cells Differentiated Therefrom
10/09/2008DE102007016367A1 Polymorph von Clarithromycin (Form V) Polymorph of clarithromycin (Form V)
10/09/2008CA2682727A1 Indoledione derivative
10/09/2008CA2682572A1 New combination for use in the treatment of inflammatory disorders
10/09/2008CA2682374A1 Medicinal composition, food or drink having effect of enhancing sympathetic nervous activity
10/09/2008CA2681979A1 Indole derivatives having cpla2 inhibiting activity and applications and production methods of the same
10/09/2008CA2680636A1 Quinoline derivatives as crth2 receptor ligands
10/08/2008EP1978096A1 Novel oligonucleotide and nf-kappa b decoy comprising the same
10/08/2008EP1978034A1 Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-related disease containing the same
10/08/2008EP1977757A2 Use of Pelargonium in combination with Plantago for the preparation of a medicament for the prevention/treatment of oral inflammation or pharyngitis
10/08/2008EP1977740A1 Composition comprising formoterol and a glucocorticosteroid
10/08/2008EP1976848A2 Phenoxypiperidines and analogs thereof useful as histamine h3 antagonists
10/08/2008EP1976839A2 Compounds and methods for modulating protein trafficking
10/08/2008EP1976833A2 Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors
10/08/2008EP1976535A2 Treatment of acute respiratory distress syndrome
10/08/2008EP1786436A4 Method for improving ventilatory efficiency
10/08/2008EP1715859B1 Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method
10/08/2008EP1646390B1 A1 adenosine receptor antagonists
10/08/2008EP1539693B9 Cannabinoid receptor agonists
10/08/2008EP1511466B1 Use of glycosaminoglycans such as e.g. heparin for the treatment of respiratory disorders such as copd
10/08/2008EP1485390B1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
10/08/2008EP1379246B1 Nociceptin analogs
10/08/2008EP1137762B1 Treatment of pompe's disease
10/08/2008EP1043995B9 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
10/08/2008EP1032667B1 Platelet specific antigens and their pharmacological uses
10/08/2008CN101282964A Oxopyridyl quinoline amides as NK3 receptor modulators
10/08/2008CN101282961A Alkylpyridyl quinolines as NK3 receptor modulators
10/08/2008CN101282950A Novel benzothiazolone derivatives
10/08/2008CN101282943A Pyrimidine amide compounds as PGDS inhibitors
10/08/2008CN101282729A Novel pharmaceutical combinations for the treatment of respiratory disorders
10/08/2008CN101282727A Use of soluble guanylate cyclase activators for treating acute and chronic lung diseases
10/08/2008CN101279997A Novel preparation of budesonide
10/08/2008CN101279092A Applications of VEGF receptor fusion protein in preparation of medicament for curing diseases about angiogenesis
10/08/2008CN101279063A Medicinal composition for treating asthma and tracheitis
10/08/2008CN101279062A Juhong Tanke dropping pill and method of preparing the same
10/08/2008CN101279056A Children's antipyretic granule
1 ... 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 ... 878